Table 3.

Adverse Clinical Events Reported During HU Therapy

Type of Adverse Event No. of Events No. of Patients
Sickle cell-related events  
 Vasoocclusive pain  76 34  
 ACS  10  8  
 Gallstones  1  
 Priapism  1  1  
 Splenic sequestration  1  
 Transient ischemic attack  1  1  
Other clinical events  
 Pain3-150 50  29  
 Nausea/vomiting  25 17  
 Infection  23  20  
 Headache  13  12 
 Diarrhea  7  6  
 Skin rash  7  5  
 Bleeding 2  1  
 Growth failure  0  
Type of Adverse Event No. of Events No. of Patients
Sickle cell-related events  
 Vasoocclusive pain  76 34  
 ACS  10  8  
 Gallstones  1  
 Priapism  1  1  
 Splenic sequestration  1  
 Transient ischemic attack  1  1  
Other clinical events  
 Pain3-150 50  29  
 Nausea/vomiting  25 17  
 Infection  23  20  
 Headache  13  12 
 Diarrhea  7  6  
 Skin rash  7  5  
 Bleeding 2  1  
 Growth failure  0  
F3-150

Pain reported by the patient that was not felt to be related to complications of sickle cell anemia by the patient and staff at participating center.

or Create an Account

Close Modal
Close Modal